Intrinsic positive end-expiratory pressure during one-lung ventilation of patients with pulmonary hyperinflation. Influence of low respiratory rate with unchanged minute volume

Br J Anaesth. 2002 Jan;88(1):56-60. doi: 10.1093/bja/88.1.56.

Abstract

Background: We measured lung mechanics and gas exchange during one-lung ventilation (OLV) of patients with chronic obstructive pulmonary disease, using three respiratory rates (RR) and unchanged minute volume.

Methods: We studied 15 patients about to undergo lung surgery, during anaesthesia, and placed in the lateral position. Ventilation was with constant minute volume, inspiratory flow and FIO2. For periods of 15 min, RR of 5, 10, and 15 bpm were applied in a random sequence and recordings were made of lung mechanics and an arterial blood gas sample was taken. Data were analysed with the repeated measures ANOVA and paired t-test with Bonferroni correction.

Results: PaO2 changes were not significant. At the lowest RR, PaCO2 decreased (from 42 (SD 4) mm Hg at RR 15-41 (4) mm Hg at RR 10 and 39 (4) mm Hg at RR 5, P<0.01), and end-tidal carbon dioxide increased (from 33 (5) mm Hg at RR 15 to 35 (5) mm Hg at RR 10 and 36 (6) mm Hg at RR 5, P<0.01). Intrinsic positive end-expiratory pressure (PEEPi) was reduced even with larger tidal volumes (from 6 (4) cm H2O at RR 15-5 (4) cm H2O at RR 10, and 3 (3) cm H2O at RR 5, P<0.01), most probably caused by increased expiratory time at the lowest RR.

Conclusion: A reduction in RR reduces PEEPi and hypercapnia during OLV in anaesthetized patients with chronic obstructive lung disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carbon Dioxide / blood
  • Humans
  • Middle Aged
  • Monitoring, Intraoperative
  • Oxygen / blood
  • Partial Pressure
  • Positive-Pressure Respiration, Intrinsic / physiopathology*
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Respiration, Artificial / methods*
  • Respiratory Mechanics*
  • Thoracotomy*

Substances

  • Carbon Dioxide
  • Oxygen